Patient Capital Management 13F, Q1 2024

Samantha McLemore · quarter ending 31 March 2024 · filed 15 May 2024 · SEC CIK 1854794

$2.05B
Filed US book
42
Positions
5.7%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q1 2024

The 25 largest of 42 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2023 filing.

CompanyTickerValue% of bookvs Q4 2023
AMAZON COM INCAMZN$116.16M5.7%-11% shares
CITIGROUP INCC$112.38M5.5%-6% shares
EXPEDIA GROUP INCEXPE$100.50M4.9%-22% shares
ONEMAIN HLDGS INCOMF$95.22M4.6%-13% shares
DELTA AIR LINES INC DELDAL$91.74M4.5%unchanged
ALPHABET INCGOOGL$90.79M4.4%unchanged
ENERGY TRANSFER L PET$89.32M4.3%unchanged
GENERAL MTRS COGM$81.53M4.0%-4% shares
META PLATFORMS INCMETA$80.12M3.9%-12% shares
IAC INCPPLI$76.67M3.7%+5% shares
UBS GROUP AG$71.88M3.5%-5% shares
MATTEL INCMAT$62.73M3.0%-4% shares
CROCS INCCROX$60.26M2.9%unchanged
COINBASE GLOBAL INCCOIN$57.75M2.8%-6% shares
NVIDIA CORPORATIONNVDA$54.76M2.7%new
UNITED AIRLS HLDGS INCUAL$53.16M2.6%-9% shares
NORWEGIAN CRUISE LINE HLDG L$50.51M2.5%-5% shares
CANADA GOOSE HLDGS INCGOOS$49.85M2.4%+8% shares
TRAVEL PLUS LEISURE COTNL$48.44M2.4%-12% shares
KOSMOS ENERGY LTDKOS$47.91M2.3%+26% shares
BIOGEN INCBIIB$46.98M2.3%new
ALIBABA GROUP HLDG LTDBABA$45.82M2.2%+10% shares
CVS HEALTH CORPCVS$45.67M2.2%-5% shares
SEADRILL 2021 LTD$45.29M2.2%+36% shares
JPMORGAN CHASE & COJPM$43.41M2.1%-19% shares

What changed since Q4 2023

Against the Q4 2023 filing, Patient Capital Management opened 3 new positions, added to 7, trimmed 20, left 12 unchanged and exited 4. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

  • CLFwas $20.97M
  • KARUNA THERAPEUTICS INCwas $3.68M
  • 2U INCwas $3.56M
  • SPYwas $994.0K

Added to

  • PPLI+5%$76.67M
  • GOOS+8%$49.85M
  • KOS+26%$47.91M
  • BABA+10%$45.82M
  • SEADRILL 2021 LTD+36%$45.29M
  • ROYALTY PHARMA PLC+13%$43.12M
  • PGEN+9%$25.31M

Trimmed

  • AMZN-11%$116.16M
  • C-6%$112.38M
  • EXPE-22%$100.50M
  • OMF-13%$95.22M
  • GM-4%$81.53M
  • META-12%$80.12M
  • UBS GROUP AG-5%$71.88M
  • MAT-4%$62.73M

and 12 more

Other quarters

Source: SEC Form 13F-HR, accession 0001085146-24-002548, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.